Holdings Inc. and Lifecore's common stock will be delisted from and will
cease to trade on the NASDAQ Stock Market. SBT Holdings Inc., SBT
Acquisition Inc. and Lifecore Biomedical, Inc. intend to complete the
merger as soon as practicable following the satisfaction of the conditions
in the Merger Agreement.
About Lifecore Biomedical, Inc.
Lifecore Biomedical, Inc. (Nasdaq: LCBM), in business over 40 years,
develops, manufactures and markets biomaterials and medical devices for use
in various surgical markets through two divisions, the Dental Division and
the Hyaluronan Division. The Dental Division conducts its dental surgery
business through direct sales and marketing in the United States, France,
Germany, Italy and Sweden and through distributors in 49 other countries.
The Hyaluronan Division conducts its business through OEM and contract
manufacturing alliances in the ophthalmic, orthopedic and veterinary
surgical fields. News and general information are available through the
Company's website at http://www.lifecore.com.
About Warburg Pincus
Warburg Pincus has been a leading private equity investor since 1971.
The firm currently has more than $20 billion of assets under management
with more than $10 billion available for investment. Warburg Pincus invests
in a range of sectors, including healthcare, financial services, consumer
and retail, industrial, business services, energy, real estate, technology,
media and telecommunications. Warburg Pincus has raised 12 private equity
investment funds which have invested more than $29 billion in approximately
585 companies in 30 countries. The firm has invested $6.2 billion in
healthcare-related companies around the world, Page: 1 2 3 Related biology technology :1
. Hearing Scheduled in the Delaware Court of Chancery for August 27, 2007 to Establish the Valid Approval and Consummation of the Merger Between PharmAthene, Inc. and Healthcare Acquisition Corp.2
. Proceedings to Affirm Merger Between PharmAthene and Healthcare Acquisition Corp Initiated in Delaware Chancery Court3
. Drug Royalty Corporation (DRC) Announces Acquisition Regarding PEG-INTRON(R) From Enzon Pharmaceuticals, Inc. (ENZN)4
. NxStage Medical Provides Update on Medisystems Acquisition5
. Palatin Technologies Announces Reacquisition of Full Rights to Bremelanotide Program6
. Validus Pharmaceuticals Expands Product Portfolio with Acquisition of Bipolar Drug: Equetro(R)7
. Federal Trade Commission Clears Kyphons Acquisition of Non-Vertebroplasty Spine-Related Assets of Disc-O-Tech8
. Shanghai Century Acquisition Corporation Announces Sichuan Kelun Pharmaceutical Co Results for the Six Months Ended June 30, 20079
. Advanced Bio-Technologies Inc Announces Acquisition by HealthEdge Investment Partners, Tampa FL10
. PAREXEL International Completes Acquisition of APEX International Clinical Research Co., Ltd.11
. PAREXEL International Updates Financial Guidance in Conjunction with the Acquisition of APEX International Clinical Research Co., Ltd. and Other Factors